Why TransCode Therapeutics Shares Are Trading Lower By Over 24%? Here Are Other Stocks Moving In Friday's Mid-Day Session

Shares of TransCode Therapeutics, Inc. RNAZ fell sharply during Friday’s session.

TransCode Therapeutics priced a 5,942,623 share common stock offering at $1.22 per share.

TransCode Therapeutics shares dipped 24.3% to $0.8248 on Friday.

Here are some other stocks moving in today's mid-day session.

Gainers

  • Charge Enterprises, Inc. CRGE shares surged 105.4% to $0.2510.
  • Kaman Corporation KAMN shares climbed 101.3% to $45.14 after the company announced it will be acquired by Arcline for $1.8 billion.
  • Mesa Air Group Inc MESA gained 70.4% to $1.09 as the company entered into new agreements with United Airlines for improved operating and financing terms.
  • Edgewise Therapeutics, Inc. EWTX rose 37.3% to $13.30 after the company announced pricing of its $240 million underwritten offering of 21,818,182 shares at $11 per share.
  • Processa Pharmaceuticals, Inc. PCSA climbed 34.2% to $0.2725. Processa Pharmaceuticals announced plans to expand the development of next generation capecitabine (NGC-Cap) into advanced or metastatic breast cancer beginning with next Phase 2 trial in breast cancer.
  • Tricon Residential Inc. TCN shares gained 28.2% to $11.06 Blackstone and Tricon Residential entered into an arrangement agreement under which Blackstone Real Estate Partners X together with Blackstone Real Estate Income Trust, Inc. will acquire all outstanding common shares of Tricon for $11.25 per share in cash.
  • Spirit Airlines, Inc. SAVE jumped 24% to $7.06 after the company announced preliminary fourth-quarter and full year 2023 estimates, issued first-quarter 2024 guidance and said the merger agreement between the company and JetBlue "remains in full force and effect."
  • Super Micro Computer, Inc. SMCI climbed 23.1% to $383.31 after the company announced updated financial guidance for the second-quarter, which surpassed its previous outlook.
  • Allied Gaming & Entertainment Inc. AGAE rose 20.6% to $1.1190.
  • Portage Biotech Inc. PRTG gained 19% to $1.14.
  • ProMIS Neurosciences, Inc. PMN gained 19% to $2.07.
  • Shuttle Pharmaceuticals Holdings, Inc. SHPH gained 16.4% to $0.5185.
  • Treasure Global Inc. TGL shares rose 14.2% to $0.1176. Treasure Global and AIO Synergy recently entered into a strategic alliance aimed at reshaping the landscape of artificial intelligence.
  • Silk Road Medical, Inc SILK jumped 13.1% to $14.91 after Stifel upgraded the stock from Hold to Buy and raised its price target from $9 to $20.
  • Wayfair Inc. W jumped 11.6% to $56.81 after the company announced a workforce realignment plan, which includes a workforce reduction involving approximately 13% of its global workforce.
  • Bullfrog AI Holdings, Inc. BFRG gained 10.6% to $4.30.
  • NewAmsterdam Pharma Company N.V. NAMS rose 10.5% to $19.44.
  • World Acceptance Corporation WRLD gained 10.2% to $134.00 following upbeat quarterly results.
  • Ally Financial Inc. ALLY gained 9.4% to $35.15. Synchrony Financial announced plans to acquire Ally Financial's point of sale financing business. Ally Financial also posted upbeat quarterly sales.
  • Cyngn Inc. CYN surged 8.8% to $0.1468 after gaining over 5% on Thursday.
  • Mesoblast Limited MESO gained 8.1% to $1.86 after the FDA granted a Rare Pediatric Disease Designation to the company’s Revascor® for treating children with congenital heart disease.
  • WNS (Holdings) Limited WNS rose 4.4% to $65.71. Needham analyst Mayank Tandon maintained WNS with a Buy and raised the price target from $80 to $85.

Losers

  • C3is Inc. CISS shares fell 63.2% to $0.1384 as the company announced pricing of $7.0 million upsized underwritten public offering.
  • Azitra, Inc. AZTR dipped 31.8% to $1.3976 after the company filed for a firm commitment public offering of 3 million shares of common stock.
  • iRobot Corporation IRBT fell 30% to $16.53 following a report suggesting the EU plans to block Amazon's acquisition of the company.
  • Accelerate Diagnostics, Inc. AXDX fell 27.1% to $1.17 after the company reported pricing of approximately $15 million public offering and private placement.
  • AST SpaceMobile, Inc. ASTS declined 24.3% to $3.15. AST SpaceMobile announced a $100 million offering of common stock. The company also announced a strategic investment from AT&T Inc T,
  • Alphabet Inc GOOG GOOGL and Vodafone.
  • Agrify Corporation AGFY dipped 21.9% to $1.0699. Agrify entered into a multi-million dollar sales agreement with Ocean Deep/Golden Lake Business Park.
  • Adagene Inc. ADAG fell 21.6% to $2.64.
  • BioCardia, Inc. BCDA fell 20% to $0.46.
  • Volato Group, Inc. SOAR fell 17.2% to $2.1688.
  • Datasea Inc. DTSS shares fell 16.4% to $0.1140. Datasea announced plans for a 1-for-15 reverse stock split to regain compliance with Nasdaq minimum bid requirement.
  • Orgenesis Inc. ORGS dipped 15.3% to $0.2711.
  • Wheels Up Experience Inc. UP fell 12.6% to $3.19.
  • Nkarta, Inc. NKTX fell 12.2% to $7.47.
  • Vision Marine Technologies Inc. VMAR shares fell 11.5% to $0.7098. Vision Marine Technologies announced close of $3.0 million private placement of convertible preferred shares and warrants with Investissement Québec.
  • Absci Corporation ABSI dipped 11.3% to $3.2120.
  • Lithium Americas Corp. LAC fell 10.4% to $4.3650.
  • Celsius Holdings, Inc. CELH fell 10% to $53.60 after B of A Securities downgraded the stock from Buy to Neutral and announced a $65 price target.
  • Hut 8 Corp. HUT dipped 9.4% to $6.45.
  • Lifezone Metals Limited LZM fell 9.3% to $6.37.
  • MorphoSys AG MOR fell 7.3% to $9.49 after falling 6% on Wednesday. Morgan Stanley analyst James Quigley, on Tuesday, downgraded MorphoSys from Overweight to Equal-Weight.
  • Hertz Global Holdings, Inc. HTZ declined 6.6% to $8.40 after Jefferies downgraded the stock from Buy to Hold and lowered its price target from $12 to $8.
  • Esperion Therapeutics, Inc. ESPR shares fell 6.1% to $2.0188. Esperion priced its $85.1 million public offering of 56.7 million common share at $1.50 per share.
  • Chegg, Inc. CHGG shares fell 6.1% to $9.45. Goldman Sachs analyst Eric Sheridan downgraded Chegg from Neutral to Sell and lowered the price target from $10 to $8.

 

Now Read This: Jim Cramer Predicts A 'Terrific Year' For This Manufacturer, And As For U-Haul? 'I'm Fine With It'

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!